市場調查報告書
商品編碼
1454043
到 2030 年醫療保健市場中的 eConsent 預測:按平台、註冊類型、表格類型、應用程式、最終用戶和地區進行的全球分析EConsent in Healthcare Market Forecasts to 2030 - Global Analysis By Platform (Web-Based and Cloud-Based), Enrollment Type, Form Type, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球醫療保健電子同意市場規模為 4.321 億美元,預計到 2030 年將達到 10.356 億美元,預測期內複合年成長率為 13.3%。
在醫療保健領域,電子同意是指患者使用數位平台和電子系統對醫療保健行動、程序和參與研究提供知情同意的電子流程。使用電子簽章、線上表單和數位文件安全地捕獲和儲存患者同意請求。它旨在簡化同意流程,使患者和醫療保健提供者更有效率、更方便。這使得患者可以在電子同意之前按照自己的步調在線查看有關治療選擇、風險、益處和替代方案的資訊。
根據Signant Health 的「2020 年eConsent 狀況」報告,28% 的受訪者已將eConsent 與EDC 產品或臨床試驗管理系統整合,分別有17%、19% 和26% 的受訪者已將eConsent 與EDC產品整合或臨床試驗管理系統。- 與臨床實驗藥物供應管理解決方案、電子臨床實驗主文件和電子臨床結果評估整合。
更多採用電子健康記錄(EHR)
醫療保健產業正在見證電子健康記錄(EHR) 的快速採用,特別是在電子同意領域。這種整合簡化了同意流程,並為患者管理其醫療保健決策提供了更大的可及性和透明度。這種向數位同意的轉變不僅提高了效率,而且增強了患者的參與度,同時確保遵守監管標準。因此,在技術普及的推動下,市場正經歷顯著成長。
資料安全和隱私問題
隨著敏感的患者資訊變得數位化並以電子方式共用,人們擔心未授權存取、資料外洩和濫用個人醫療保健資料的可能性。確保強大的加密通訊協定、嚴格的存取控制以及遵守嚴格的隱私法規至關重要。加密措施不足和網路威脅防護措施不足是主要挑戰。
擴大數位健康工作
醫療保健領域的數位健康計劃顯著擴展,特別是電子同意解決方案的整合。透過利用行動應用程式和基於網路的入口網站等數位平台,患者可以輕鬆地遠端存取、審查和簽署同意書。這不僅提高了效率,還確保符合監管要求,並促進患者參與醫療保健決策流程並賦予其權力。
初始實施成本
市場上的初始實施成本取決於醫療機構的規模、系統的複雜性以及所需的客製化等級等因素。包括與軟體許可、硬體基礎設施、員工培訓、與現有系統整合以及遵守監管標準相關的成本。因此,這些都是阻礙市場成長的因素。
COVID-19 的疫情對醫療保健領域的電子同意市場產生了重大影響。由於需要減少社交距離和盡量減少身體接觸,醫療保健提供者擴大採用電子同意解決方案,以促進遠距患者互動。這一轉變加速了醫療保健領域的數位轉型,並導致更多地採用 eConsent 平台來獲取患者對治療、手術和臨床試驗的同意。此次疫情凸顯了高效、安全和可存取的同意流程的重要性,推動了醫療保健領域電子同意市場的成長。
預計普遍同意部分在預測期內將是最大的
在預測期內,一般同意部分預計將是最大的。這些平台上的普遍同意通常包括患者授予的常規醫療保健活動、治療和健康資訊揭露的廣泛許可。透過數位化同意流程,eConsent 解決方案提高了效率、準確性和合規性,同時使患者能夠就其護理做出明智的決定。
預計臨床試驗部分在預測期內複合年成長率最高。
預計臨床試驗部分在預測期內複合年成長率最高。這種數位方法簡化了同意流程,並提供了諸如提高參與者理解、遠端存取和即時追蹤等優勢。隨著技術的發展,eConsent 系統整合預計將透過提高參與者招募和同意流程的效率和透明度來擴展和徹底改變臨床試驗格局。
預計北美在預測期內將佔據最大的市場佔有率。 eConsent 工具提供了更大的便利性和可近性,可提高患者的參與和理解,同時確保遵守監管標準。憑藉電子簽章和互動式多媒體等功能,這些解決方案提高了透明度,促進明智的決策,並最終提高整體醫療保健領域的效率和課責。
預計亞太地區在預測期內的複合年成長率最高。 eConsent 解決方案具有多種優勢,例如增加可訪問性、加強患者教育以及提高同意流程的透明度。隨著醫療保健組織認知到數位解決方案在改善患者照護、提高業務效率和確保監管合規性方面的價值,預計該市場的採用率將繼續成長。
According to Stratistics MRC, the Global EConsent in Healthcare Market is accounted for $432.1 million in 2023 and is expected to reach $1035.6 million by 2030 growing at a CAGR of 13.3% during the forecast period. EConsent in healthcare refers to the electronic process through which patients provide their informed consent for medical treatment, procedures, or participation in research studies using digital platforms or electronic systems. It encompasses the use of electronic signatures, online forms, and digital documentation to capture and store patients' consent preferences securely. It aims to streamline the consent process, making it more efficient and accessible for both patients and healthcare providers. It allows patients to review information about their treatment options, risks, benefits, and alternatives online, at their own pace, before consenting electronically.
According to the State of eConsent 2020 report by Signant Health, 28% of survey respondents integrated eConsent with EDC products and clinical trial management systems, while 17%, 19%, and 26% integrated eConsent with randomization & trial supply management solutions, electronic trial master file, and electronic clinical outcome assessment, respectively.
Increased adoption of electronic health records (EHRs)
The healthcare industry is witnessing a surge in the adoption of electronic health records (EHRs), particularly in the realm of EConsent. The integration streamlines the consent process, offering patients greater accessibility and transparency in managing their healthcare decisions. This shift towards digital consent not only enhances efficiency but also ensures compliance with regulatory standards while bolstering patient engagement. As a result, the market is experiencing significant growth propelled by the widespread embrace of technology.
Concerns about data security and privacy
With sensitive patient information being digitized and shared electronically, there are worries about unauthorized access, data breaches, and potential misuse of personal health data. Ensuring robust encryption protocols, stringent access controls, and compliance with stringent privacy regulations is imperative. Insufficient encryption measures and inadequate safeguards against cyber threats pose significant challenges.
Expansion of digital health initiatives
The healthcare sector has seen a significant expansion of digital health initiatives, particularly in the integration of electronic consent solutions. By leveraging digital platforms, such as mobile apps or web-based portals, patients can conveniently access, review, and sign consent forms remotely. This not only improves efficiency but also ensures compliance with regulatory requirements while promoting patient engagement and empowerment in their healthcare decision-making process.
Initial implementation costs
The initial implementation costs in the market can vary depending on factors such as the size of the healthcare organization, the complexity of the system, and the level of customization required. They encompass expenses related to software licensing, hardware infrastructure, staff training, integration with existing systems, and compliance with regulatory standards. Hence, these are the factors hampering the growth of the market.
The COVID-19 pandemic has significantly impacted the eConsent in healthcare market. With social distancing measures and the need to minimize physical contact, healthcare providers are increasingly adopting electronic consent solutions to facilitate remote patient interactions. This shift has accelerated the digital transformation in healthcare, leading to greater adoption of eConsent platforms for obtaining patient consent for treatments, procedures, and clinical trials. The pandemic has underscored the importance of efficient, secure, and accessible consent processes, driving the growth of the eConsent market in healthcare.
The general consent segment is expected to be the largest during the forecast period
The general consent segment is expected to be the largest during the forecast period. General consent within these platforms typically encompasses broad permissions granted by patients for routine healthcare activities, treatments, and disclosures of health information. By digitizing the consent process, eConsent solutions enhance efficiency, accuracy, and compliance while empowering patients to make informed decisions about their care.
The clinical trails segment is expected to have the highest CAGR during the forecast period
The clinical trails segment is expected to have the highest CAGR during the forecast period. This digital approach streamlines the consent process, offering benefits such as enhanced participant comprehension, remote access, and real-time tracking. As technology evolves, the integration of eConsent systems is anticipated to grow, revolutionizing the clinical trial landscape by enhancing efficiency and transparency in participant recruitment and consent processes.
North America is projected to hold the largest market share during the forecast period. Offering greater convenience and accessibility, eConsent tools enhance patient engagement and comprehension while ensuring compliance with regulatory standards. With features like electronic signatures and interactive multimedia, these solutions improve transparency and facilitate informed decision-making, ultimately fostering efficiency and accountability across the healthcare continuum.
Asia Pacific is projected to hold the highest CAGR over the forecast period. Data security and privacy are paramount concerns in the adoption of eConsent solutions. eConsent solutions offer benefits such as improved accessibility, enhanced patient education, and greater transparency in the consent process. The adoption in the market is expected to continue growing as healthcare organizations recognize the value of digital solutions in improving patient care, enhancing operational efficiency, and ensuring regulatory compliance.
Key players in the market
Some of the key players in EConsent in Healthcare market include Citadel Group, Veeva Systems, Thieme Compliance GmbH, Wellbeing Software, Interlace Health, Florence Healthcare, 5thPort, LLC, Adobe Inc., Concentric Health Ltd, GE Healthcare, Koninklijke Philips N.V., HealthStream Inc., Cerner Corporation, Medtronic, Siemens Healthineers and ClinOne.
In June 2022, uMotif and ClinOne announced a partnership to address the challenges faced by patients & clinical research coordinators who struggle to navigate multiple systems, apps, & sensors for each protocol.
In October 2020, Veeva Systems launched two new applications built on Veeva Clinical Network - Veeva Site Connect and Veeva eConsent.